InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Lunger John, Directeur de l'Approvisionnement des Patients. Officer active across 1 company, notably Adaptimmune Therapeutics PLC. Cumulatively, 20 filings have been logged. Breakdown: 0 buy · 20 sells. Total volume traded: €126k. History available since 2 July 2021. The latest transaction was disclosed on 17 January 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations20 total
5,584 shares@ US$0.58082.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-25-004607:0
4,268 shares@ US$0.58791.9% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-25-003768:0
4,681 shares@ US$0.792.7% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-24-004562:0
4,009 shares@ US$0.83672.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-24-003744:0
3,096 shares@ US$0.90562.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-086416:0
4,440 shares@ US$1.8586.1% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-004382:0
3,843 shares@ US$1.74685.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-003538:0
1,100 shares@ US$1.6941.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-001090:0
2,983 shares@ US$1.77354.1% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-084894:0
1,973 shares@ US$1.67812.6% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-077470:0
4,368 shares@ US$3.191814.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-005055:0
4,368 shares@ US$3.19189.7% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-005055
3,770 shares@ US$3.556713.6% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-004152:0
3,770 shares@ US$3.55679.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-004152
1,070 shares@ US$4.06424.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-001670:0
1,070 shares@ US$4.06423.1% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-001670
2,939 shares@ US$3.584810.2% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-21-098959:0
2,939 shares@ US$3.58487.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-21-098959
1,907 shares@ US$4.26497.9% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-21-089048:0
1,907 shares@ US$4.26495.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-21-089048
20 of 20 declarations
About Lunger John
John Lunger is the Chief Patient Supply Officer at Adaptimmune Therapeutics PLC. He is responsible for managing the supply and logistics of treatments for patients. John plays a key role in optimizing supply chain processes to ensure that patients receive necessary treatments in a timely manner. His expertise in supply chain management is crucial for the success of Adaptimmune's operations.
